|
WO2021048611A1
|
|
Rifabutin treatment methods, uses, and compositions
|
|
WO2021048612A1
|
|
Rifabutin treatment methods, uses, and compositions
|
|
US2021077470A1
|
|
Rifabutin treatment methods, uses, and compositions
|
|
WO2020115547A2
|
|
Pyrrolo[2,3-d]pyrimidin-2-one antimicrobial compounds
|
|
WO2020109350A1
|
|
3-(phenylsulfonyl)-[1,2,3]triazolo[1,5a]quinazolin-5(4h)-one derivatives
|
|
WO2019234508A1
|
|
Biodefense agents
|
|
WO2019234509A2
|
|
Aminomethylamidine and methylamidine antimicrobial compounds
|
|
AU2018317805A1
|
|
Novel compounds
|
|
EP3569710A1
|
|
Bacterial vectors for genetic manipulation of bacteria
|
|
US2019211018A1
|
|
Antimicrobials and methods of making and using same
|
|
EP2762134A1
|
|
Composition for treatment of pathogens that are resistant to tetracyclines
|
|
EP2445495A1
|
|
Composition for treatment of tuberculosis
|
